BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15346623)

  • 1. [Multiple sclerosis].
    Akesson E; Fredrikson S
    Lakartidningen; 2004 Aug; 101(32-33):2489-93. PubMed ID: 15346623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spasticity and multiple sclerosis].
    Bussel B; Neris OR; Mailhan L
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1041-4. PubMed ID: 11787334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and management of cognitive disorders in multiple sclerosis--a consensus approach.
    Lensch E; Matzke M; Petereit HF; Scherer P; Schramm S; Calabrese P
    J Neurol; 2006 Feb; 253 Suppl 1():I29-31. PubMed ID: 16477483
    [No Abstract]   [Full Text] [Related]  

  • 4. Benign or not benign MS: a role for routine neuropsychological assessment?
    Benedict RH; Fazekas F
    Neurology; 2009 Aug; 73(7):494-5. PubMed ID: 19641172
    [No Abstract]   [Full Text] [Related]  

  • 5. Paroxysmal kinesigenic dystonia and spinal cord lesion.
    Cosentino C; Torres L; Flores M; Cuba JM
    Mov Disord; 1996 Jul; 11(4):453-5. PubMed ID: 8813233
    [No Abstract]   [Full Text] [Related]  

  • 6. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple sclerosis].
    Scherer C; Dubas F
    Rev Prat; 2009 May; 59(5):695-701. PubMed ID: 19552212
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive changes in multiple sclerosis.
    Amato MP; Zipoli V; Portaccio E
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in clinical therapeutic trials of multiple sclerosis.
    Jacobs L
    West J Med; 1996 Jun; 164(6):531-2. PubMed ID: 8764636
    [No Abstract]   [Full Text] [Related]  

  • 10. The neuropsychiatry of multiple sclerosis: a review of recent developments.
    Ghaffar O; Feinstein A
    Curr Opin Psychiatry; 2007 May; 20(3):278-85. PubMed ID: 17415083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the symptoms of multiple sclerosis: a multimodal approach.
    Crayton HJ; Rossman HS
    Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects and diagnosis of multiple sclerosis].
    Berger T; Deisenhammer F
    Wien Med Wochenschr; 1996; 146(19-20):504-13. PubMed ID: 9082650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The radiologically isolated syndrome revisited: when is it presymptomatic multiple sclerosis?
    Bourdette D; Yadav V
    Neurology; 2011 Feb; 76(8):680-1. PubMed ID: 21270414
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special Considerations and Assessment in Patients with Multiple Sclerosis.
    Maitin IB; Cruz E
    Phys Med Rehabil Clin N Am; 2018 Aug; 29(3):473-481. PubMed ID: 30626509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dot-to-dot.
    Thomas RH; Hughes TA
    Pract Neurol; 2008 Oct; 8(5):325-9. PubMed ID: 18796589
    [No Abstract]   [Full Text] [Related]  

  • 18. Recognition of impaired cognition in multiple sclerosis.
    Enzinger C
    Neurol India; 2006 Dec; 54(4):349. PubMed ID: 17114835
    [No Abstract]   [Full Text] [Related]  

  • 19. [Signs of atrophy and cognitive status: a new parameter in the course of MS?].
    Nervenarzt; 1999 Oct; 70(10 Suppl Atrophieze):1-8. PubMed ID: 10555525
    [No Abstract]   [Full Text] [Related]  

  • 20. A multimodal approach to managing the symptoms of multiple sclerosis.
    Crayton H; Heyman RA; Rossman HS
    Neurology; 2004 Dec; 63(11 Suppl 5):S12-8. PubMed ID: 15596731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.